Obama nominates ex-drug lobbyist as top HHS lawyer

White House/Pete Souza

Article Highlights

  • Obama administration nominates ex-drug lobbyist as top @HHSGov lawyer

    Tweet This

  • Appointing a drug lobbyist as the top lawyer at HHS clashes with Obama's rhetoric about battling special interests

    Tweet This

  • "Nominating a drug lobbyist to help implement and defend Obamacare is only fitting." @TPCarney

    Tweet This

The Obama administration has nominated a former lobbyist for drug companies and hospitals to be the top lawyer at the Department of Health and Human Services.

William Schultz's nomination as general counsel of HHS once again demonstrates that Obama's lobbyist restrictions were toothless, and that Obamacare made the revolving door spin faster. The Senate Finance Committee is scheduled to consider Schultz's nomination Thursday.

Schultz, whose wife is Washington Post investigative reporter Sari Horwitz, spent 13 years as an attorney for Ralph Nader's crusading "consumer advocacy" group Public Citizen. In 1989, Schultz went to Capitol Hill as counsel for the health and environment subcommittee of the House Energy and Commerce Committee. He then spent seven years in the Clinton administration, mostly as deputy commissioner of the Food and Drug Administration.

At the end of Clinton's term, Schultz cashed out, becoming a lobbyist at the K Street firm Zuckerman Spaeder. National Journal reported at the time, "As a partner at the Washington-based national law firm, Schultz expects to capitalize on his work for nonprofits, as well as his experience in food and drug law."

He did. Over eight years, Schultz lobbied on behalf of seven different drug companies, plus the American Hospital Association, according to lobbying disclosure filings. The firm brought in $2.98 million from Schultz's lobbying, according to the filings.

Nearly half of that money -- $1.46 million -- came from Schultz's biggest client, Barr Laboratories, maker of the morning-after contraception pill known as Plan B. HHS Secretary Kathleen Sebelius in 2011 issued a rule requiring nearly all employer-based health plans to cover 100 percent of the cost of Plan B along with other contraceptives.

A handful of lawsuits have challenged this mandate. As general counsel for HHS, Schultz would presumably be the point man on defending the mandate. Has he been recusing himself? Schultz's office dodged my question on the subject.

Plenty of other litigation facing Schultz directly affects his former clients. Oklahoma, for instance, is challenging HHS's authority to subsidize federally established insurance exchanges. The drug companies and hospitals Schultz represented take the administration's side, lobbying for more federal subsidies of health insurance.

Appointing a drug and hospital lobbyist as the top lawyer at HHS clashes with Obama's rhetoric about battling the special interests and keeping lobbyists out of the administration. But Schultz is apparently not covered by Obama's anti-lobbyist rules.

Obama's "lobbyist ban" applies only to lobbyists who have registered as such within two years of their appointment. Zuckerman Spaeder terminated all its lobbying filings on Sept. 30, 2008. Schultz's personal financial disclosures show that he kept at least some lobbying clients -- including drug companies -- as legal clients.

Two weeks after deregistering as a lobbyist in 2008, Schultz contributed the maximum $2,300 to Obama's campaign, thus not running afoul of the Obama campaign's trumpeted rejection of lobbyist contributions. Obama appointed Schultz as HHS deputy general counsel two and a half years later, and he now serves as acting general counsel.
"Nominating a drug lobbyist to help implement and defend Obamacare is only fitting."
Obama on his first day issued an executive order barring all appointees -- not merely lobbyists -- from participating in "any particular matter involving specific parties that is directly and substantially related to my former employer or former clients." Nearly every disputed aspect of Obamacare greatly affects Schultz's former drug and hospital clients, but the legal definition of "substantially related to" is pretty narrow.

I called HHS to ask in what specific matters Schultz recused himself. HHS spokesman Tait Sye wrote back with this answer: "Bill Schultz assiduously complies with the stringent standards set by the President's Executive Order on Ethics, including recusal matters. Bill has not been a registered lobbyist since the fall of 2008, which is more than 2 years prior to his appointment at HHS."

Schultz is hardly the first revolving-door lobbyist to work on Obamacare within the Obama administration. To help implement the bill after it passed, HHS hired insurance lobbyist-turned-Senate staffer Liz Fowler as policy director. After Obama's re-election, she cashed out again to take over the lobbying operation of pharmaceutical giant Johnson & Johnson.

Increasing government's role in the economy fuels the revolving door by creating more demand for lobbyists with connections to government. Obamacare was extraordinary in this regard. Nominating a drug lobbyist to help implement and defend Obamacare is only fitting.

Also Visit
AEIdeas Blog The American Magazine
About the Author


Timothy P.

What's new on AEI

Love people, not pleasure
image Oval Office lacks resolve on Ukraine
image Middle East Morass: A public opinion rundown of Iraq, Iran, and more
image Verizon's Inspire Her Mind ad and the facts they didn't tell you
AEI on Facebook
Events Calendar
  • 21
  • 22
  • 23
  • 24
  • 25
Monday, July 21, 2014 | 9:15 a.m. – 11:30 a.m.
Closing the gaps in health outcomes: Alternative paths forward

Please join us for a broader exploration of targeted interventions that provide real promise for reducing health disparities, limiting or delaying the onset of chronic health conditions, and improving the performance of the US health care system.

Monday, July 21, 2014 | 4:00 p.m. – 5:30 p.m.
Comprehending comprehensive universities

Join us for a panel discussion that seeks to comprehend the comprehensives and to determine the role these schools play in the nation’s college completion agenda.

Tuesday, July 22, 2014 | 8:50 a.m. – 12:00 p.m.
Who governs the Internet? A conversation on securing the multistakeholder process

Please join AEI’s Center for Internet, Communications, and Technology Policy for a conference to address key steps we can take, as members of the global community, to maintain a free Internet.

Event Registration is Closed
Thursday, July 24, 2014 | 9:00 a.m. – 10:00 a.m.
Expanding opportunity in America: A conversation with House Budget Committee Chairman Paul Ryan

Please join us as House Budget Committee Chairman Paul Ryan (R-WI) unveils a new set of policy reforms aimed at reducing poverty and increasing upward mobility throughout America.

Thursday, July 24, 2014 | 6:00 p.m. – 7:15 p.m.
Is it time to end the Export-Import Bank?

We welcome you to join us at AEI as POLITICO’s Ben White moderates a lively debate between Tim Carney, one of the bank’s fiercest critics, and Tony Fratto, one of the agency’s staunchest defenders.

No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.